Asthma Trial, Recruiting (NCT06237660)

Asthma Trial, Recruiting NCT06237660 Sponsor: Imperial College London Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06237660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child must be between 1 and 5 years old
The child has been admitted to hospital more than twice in the last year due to sudden episodes of wheezing, OR
The child has had at least one hospital stay in the last year that required intensive monitoring or treatment through a drip to open up the airways
For one part of the study only: the child is already scheduled to have a camera procedure to look inside their airways as part of their normal medical care, as decided by their own doctors

Who may not be able to join:

The child has been diagnosed with a different lung or breathing condition, such as cystic fibrosis or a condition involving damaged airways (bronchiectasis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sejal Saglani, MD, Imperial College London

Phone: +4420 7594 9832

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06237660

Sponsor: Imperial College London

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

Trial contact: +4420 7594 9832

More information: https://clinicaltrials.gov/study/NCT06237660

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child must be between 1 and 5 years old
The child has been admitted to hospital more than twice in the last year due to sudden episodes of wheezing, OR
The child has had at least one hospital stay in the last year that required intensive monitoring or treatment through a drip to open up the airways
For one part of the study only: the child is already scheduled to have a camera procedure to look inside their airways as part of their normal medical care, as decided by their own doctors

Who may not be able to join:

The child has been diagnosed with a different lung or breathing condition, such as cystic fibrosis or a condition involving damaged airways (bronchiectasis)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Imperial College London

Registry

ClinicalTrials.gov

Start date

1 February 2024

Est. completion

31 August 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Longitudinal study of skin prick tests as biomarkers of preschool wheeze; Longitudinal study of finger-prick point of care test for eosinophil count as a biomarker of preschool wheeze; Longitudinal study of blood neutrophil phenotype as a biomarker of airway infection; Longitudinal study of blood neutrophil chemotaxis as a biomarker of wheezing phenotype; Longitudinal study of oropharyngeal swab and induced sputum PCR as a biomarker of airway infection; Longitudinal study of lung function test (FOT) as a biomarker of airway reversibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov